The drug testing service CheQpoint has identified the presence of phenacetin, a banned painkiller, in cocaine samples tested on the Gold Coast, raising concerns about the potential circulation of this harmful substance in other parts of the country. Phenacetin, which was prohibited in Australia many years ago due to its association with renal disease and cancer in long-term users, was discovered in two samples of cocaine analyzed at CheQpoint's newly established facility in Burleigh Heads.
CheQpoint's chief executive, Cameron Francis, emphasized the short-term and long-term risks associated with phenacetin, highlighting the danger of rapid depletion of blood oxygen in cases of overdose. Additionally, he pointed out that symptoms of phenacetin poisoning can be challenging to detect, urging healthcare professionals to remain vigilant. Working in collaboration with organizations like Queensland Injectors Health Network and Queensland Injectors Voice for Advocacy and Action, CheQpoint aims to raise awareness about the dangers of substances like phenacetin in illicit drugs.
The detection of phenacetin in cocaine samples underscores the importance of free drug testing services like CheQpoint, as noted by Bond University's associate professor of pharmacology, Treasure McGuire. Dr. McGuire emphasized the role of harm-minimization strategies in educating individuals about the risks associated with illegal substances and potentially influencing their future decision-making regarding drug use. The continued availability of drug testing locations is seen as a critical measure in promoting the safety and well-being of individuals who may be exposed to harmful substances unknowingly.